Literature DB >> 9798669

Early ticlopidine-induced hepatic dysfunction, dermatitis and irreversible aplastic anemia after coronary artery stenting.

C Ceylan, O Kirimli, M Akarsu, B Undar, S Güneri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9798669     DOI： 10.1002/(sici)1096-8652(199811)59:3<260::aid-ajh16>3.0.co;2-5

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

1.  Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.

Authors:  F L Paradiso-Hardy; C M Angelo; K L Lanctôt; E A Cohen
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

2.  Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report.

Authors:  Antonino M Previtera; Rossella Pagani
Journal:  J Med Case Rep       Date:  2010-08-12

Review 3.  Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs.

Authors:  Kathrin Scherer Hofmeier
Journal:  Allergo J Int       Date:  2015-03-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.